COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

Dr. Yun-Shang Piao

Dr. Yun-Shang Piao

Scientific Review Officer



Biography

Division:
Division of Physiological and Pathological Sciences DPPS
IRG:
Endocrinology, Metabolism, Nutrition and Reproductive Sciences EMNR
Study Section:
Systemic Injury by Environmental Exposure SIEE

Dr. Yun-shang Piao obtained his Ph.D. in biochemistry and molecular biology from the University of Oulu, Finland. He later became a principle investigator or senior researcher at the Chinese Academic of Sciences; Karolinska Institute in Sweden; MD Anderson Cancer Center in Houston, Texas; Montana State University; and NIH. He performed basic research in reproductive sciences, endocrinology, and hormone-related cancers. Before coming to NIH, he served as a scientific reviewer at FDA. He conducted premarket reviews of cellular therapy products and the total product life cycle review of reproductive and ob/gyn devices, including premarket/postmarket submissions, manufacturing, recall, allegation, etc.